We are live on ! Find out more
SLXNW

Silexion Therapeutics Warrant
SLXNW

31 hedge funds and large institutions have $106K invested in Silexion Therapeutics Warrant in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
–
Reduced
–
Closed
–
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
+$43K
2
LA
Linden Advisors
New York
+$19.5K
3
AC
Aristeia Capital
Connecticut
+$14K
4
HP
Hartree Partners
New York
+$10.9K
5
SBLIC
Security Benefit Life Insurance Company
Kansas
+$8.69K

Top Sellers

No sellers this quarter

SLXNW Hedge Fund Activity: Q3 2024 in Review

31 of the 6,981 institutional investors tracked by Wall St. Rank reported a position in Silexion Therapeutics Warrant (SLXNW) for Q3 2024, worth a combined $106K.

Buyers outnumbered sellers: 31 funds opened new SLXNW positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Polar Asset Management Partners, opening a new position worth an estimated $43K.

  • 31 institutional investors held Silexion Therapeutics Warrant (SLXNW) as of Q3 2024, up from 0 in Q2 2024.
  • Funds reported $106K of Silexion Therapeutics Warrant stock for Q3 2024.
  • 31 funds opened new Silexion Therapeutics Warrant positions in Q3 2024 and 0 closed out, a net change of +31 holders.
  • The largest Silexion Therapeutics Warrant buyer in Q3 2024 was Polar Asset Management Partners, an estimated $43K added.

Based on aggregated 13F filings for Q3 2024.